VYNE Therapeutics Inc.
Price Action
Technical Summary
EMERGING TRENDVYNE Therapeutics Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is moderate (RS Rating: 78), indicating performance broadly in line with the market. Earnings growth of 58% provides fundamental context to the price action. Investors should exercise caution due to high volatility (119% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.65 | -0.92% | BELOW |
| 50 SMA | $0.66 | -1.45% | BELOW |
| 100 SMA | $0.63 | +3.38% | ABOVE |
| 150 SMA | $0.58 | +10.76% | ABOVE |
| 200 SMA | $0.53 | +22.98% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is VYNE in an uptrend right now?
VYNE has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is VYNE overbought or oversold?
VYNE's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.
Is VYNE outperforming the market?
VYNE has a Relative Strength (RS) Rating of 78 out of 99. VYNE is performing about average compared to the market.
Where is VYNE in its 52-week range?
VYNE is trading at $0.65, which is 33% of its 52-week high ($1.96) and 22% above its 52-week low ($0.28).
How volatile is VYNE?
VYNE has a Beta of 0.46 and 52-week volatility of 119%. It's less volatile than the S&P 500 - generally more stable.